• PaXini Tech

  Led · Equity · Aug 2026

  PaXini develops full-stack embodied perception products—haptic chips, sensors, and multimodal data pipelines—positioning itself as an infrastructure and standards contributor for Physical AI. Over the past year the company reported near-1 million units of self-developed haptic chip consumption, and its multimodal haptic data has been adopted by leading embodied intelligence foundation model companies and major internet technology firms. PaXini says it has achieved product-market fit in the perception track and operates large-scale embodied intelligence data collection factory clusters to produce structured multimodal haptic data. Its core patents reportedly cover major global markets, and the company is building localized operations and delivery systems in North America, Japan, South Korea, and Europe. PaXini's customer matrix has penetrated core global supply chains, and the company emphasizes its role as a foundation for delivering standardized physical interaction data to embodied models. The company aims to scale global commercial deployment and deepen integration with world-class supply chains as it expands internationally.

• Galaxy Bot

  Participated · Equity · Mar 2026

  Founded in May 2023 by Peking University professor Wang He, Galaxy Universal Robotics builds general-purpose humanoid robots that integrate high-level perception, cognitive planning, and low-level motor control through its self-developed “AstraBrain” embodied large model. The company pairs this model with the world’s largest embodied-intelligence dataset (tens of billions of data points) and a virtual-real fusion training system called “AstraSynth,” which it claims yields 1,000× higher training efficiency than Tesla and a 99 % task-success rate. Flagship robot Galbot S1 already performs fully autonomous work inside CATL battery factories and carries 50 kg dual-arm payloads under harsh industrial conditions. Commercial pilots span hundreds of “Galaxy Space Capsule” retail stores, 24-city smart-pharmacy networks managing 5,000 SKUs, and deployments in top hospitals such as Xuanwu and West China. Industrial partners include CATL, Bosch, Toyota, BAIC, and SAIC, with cumulative industrial orders in the thousands. The firm’s valuation topped US $3 billion after a late-2025 round and “continues to lead the humanoid robot industry,” supported by record cumulative fundraising that now exceeds any peer in China.

No current team members are available.